Comparison Between Intraligamentary Piroxicam and Articaine

• Status: Unknown status
• Trial end date: 2019-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparing the efficacy of intra-ligamentary Piroxicam and intra-ligamentary Articaine on pain during and after endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Carticaine; Piroxicam

Criteria

Inclusion Criteria:

• Healthy and medically free patients.

• Acute symptomatic irreversible pulpitis of the mandibular first or second molar teeth.

• Vital teeth with no history of previous root canal treatment.

• Teeth that could be treated endodontically in single visit.

• Teeth with normal periodontium, not sensitive to percussion with no periapical radiolucency.

• Patients able to understand numerical rating scale and sign the informed consent.

Exclusion Criteria:

• Known hypersensitivity to piroxicam.

• Pregnancy or lactation.

• Asthma or allergy to other anti-inflammatory drugs.

• History of peptic ulceration.

• Teeth associated with swelling or fistulous tract, acute or chronic periapical abscess.